Media

Basel Area Business & Innovation, is the official investment and innovation promotion agency for the Basel Area.
As a journalist, we provide you with press releases, story ideas, images, and facts within areas of general business information, investments and innovation. If you are about to visit the Basel Area, contact us to make sure you will get the most out of your stay.
Email our media team

Media releases

In the Basel Area the healthtech sector is booming

Canton of Jura is the newest site of the Switzerland Innovation Park Basel Area

Go-ahead for unique innovation campus in Allschwil

Who will seize the opportunity?

33 recently arrived companies create hundreds of jobs in the Basel region.

Useful links and downloads

Facts about Basel Area

Facts about Basel Area Business & Innovation

Image bank

Basel Area logo (color)

Basel Area logo (B&W)

Contact media relations

Martin Jordan

Manager Media and Public Relations

Contact me to get help with your story about the Basel Area. Receive the latest investment and innovation promotion news, facts, images and stories about our region.

   +41 61 295 50 25

Email Martin

View our latest news

Basel Area Business & Innovation, Innovation

T3 Pharma raises over 25 million Swiss francs

T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.

Read More
Basel Area Business & Innovation, Innovation

Versameb raises 6 million Swiss francs

The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.

Read More
Basel Area Business & Innovation, Innovation

Genedata accelerating drug development

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Read More